Medical University Of Warsaw
Clinical trials sponsored by Medical University Of Warsaw, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Long-Term heart risks after rare COVID complication in kids under scrutiny Results expected Oct 2026 (estimated)
- Can a single protein explain Asthma's many faces? Results expected Nov 2026 (estimated)
- Can Quick-Trained operators get accurate heart ultrasound readings? Results expected Dec 2026 (estimated)
- Can poop pills beat superbugs? new trial aims to stop antibiotic resistance Results expected Feb 2027 (estimated)
- Could removing catheters sooner after kidney transplant cut infections? Results expected Mar 2027 (estimated)
-
Could removing catheters sooner after kidney transplant cut infections?
Disease control OngoingThis trial tests whether removing the urinary catheter within 24 hours after a kidney transplant is as safe as keeping it longer. The goal is to see if early removal reduces urinary tract infections without increasing the risk of urine leaks or narrowing of the ureter. About 120 …
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy may simplify steroid diabetes care
Disease control By invitation onlyThis study tests whether a combination of a GLP-1 drug (lixisenatide) plus long-acting insulin works better than standard intensive insulin therapy for people whose diabetes is caused by steroid medications. About 100 adults with conditions like asthma or arthritis who need long-…
Phase 4 • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 26, 2026 19:20 UTC
-
Glowing light could spot oral cancer before it starts
Prevention By invitation onlyThis study investigates whether a painless fluorescent light exam can help find early warning signs of oral cancer in adults. Participants complete a health questionnaire and receive a standard oral exam plus a fluorescence scan. The goal is to see if this simple, non-invasive to…
Sponsor: Medical University of Warsaw • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Could a common asthma drug help newborns breathe easier?
Symptom relief OngoingThis phase 3 trial tests whether inhaled salbutamol, a drug used for asthma, can help newborns with transient tachypnoea (rapid breathing after birth). About 608 babies born between 32 and 42 weeks will receive either salbutamol or a placebo. The goal is to see if the drug reduce…
Phase 3 • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Nurses take the lead: can they master PICC placement?
Knowledge-focused OngoingThis study in Poland is checking how well a specially trained nursing team can insert PICCs (a type of long-term IV line) in 200 adult patients who need them for treatments like chemotherapy or nutrition. The main goal is to see how often they succeed on the first try. It's an ob…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Tiny sensor may spot hidden diabetes risk from common steroids
Knowledge-focused By invitation onlyThis study looks at 250 adults who are starting steroid treatment for conditions like autoimmune disease or inflammation. Researchers will use a continuous glucose monitor (CGM) for 14 days to see if it can detect early signs of steroid-induced diabetes better than standard tests…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC